Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04866966 · ClinicalTrials.gov registry record · NA
Shared Medical Appointments for Weight Loss
A NA study, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT04866966: Completed NA study, sponsored by University of South Florida.
NCT04866966 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04866966, a NA study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
Randomized controlled trial to determine if a 6 months of shared medical appointments will results in clinically and statistically significant weight loss.
Primary Outcome
Body weight will be measured at the initial and final visits using the Tanita DC-430 body composition analyzer for participants in both groups and documented in the medical record. Percent of body weight lost will be calculated for each participant and the percentage of participants who lose 5% of body weight will be included in the primary outcome.
Interventions
- BEHAVIORAL Shared medical appointments for weight loss
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-02-27 |
| Est. Completion | 2019-08-21 |
| Phase | NA |
What the finished NCT04866966 record still lists
NCT04866966 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Shared medical appointments for weight loss is the first listed.
NCT04866966 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04866966 about?
NCT04866966 is a clinical study titled "Shared Medical Appointments for Weight Loss". Randomized controlled trial to determine if a 6 months of shared medical appointments will results in clinically and statistically significant weight loss.
What is the current status of trial NCT04866966?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2019-02-27. Estimated completion is 2019-08-21.
What interventions are being tested in trial NCT04866966?
The interventions under investigation include: Shared medical appointments for weight loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT04866966?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04866966's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI